Purchase Order 36C24419P0283
- Not listed
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, provides instrumentation and supplies for COVID-19 diagnostic testing. The $148,585 delivery order was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration and is not set aside. Cepheid is the prime contractor and will deliver COVID-19 testing equipment, reagents, and consumables to support the VA's clinical diagnostic programs. As the original equipment...
- This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including infectious disease testing products. The contract is for $61,730.25 and has a completion date of September 30, 2024. Cepheid will provide reagents, test kits, and supplies compatible with the Cepheid GeneXpert PCR lab test analysis system to support clinical testing programs serving...
- This is a federal contract award made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. Cepheid will provide reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. The contract has a completion date of September 30, 2019, an award date of October 9, 2018, and a potential value of $127,763.15. The contract is a purchase order with a firm fixed price...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, on September 28, 2018. The $148,585 contract is under the VA's Scientific Equipment and Services Federal Supply Schedule (FSS-66) and provides Cepheid's diagnostic testing equipment, reagents, and consumables to support the VA's clinical diagnostic programs. The contract does not have a set-aside designation....
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $256,814.60 contract provides reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. Cepheid is the original equipment manufacturer for these products. The order is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract vehicle...
- This is a $724,021.62 firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the delivery of molecular PCR (polymerase chain reaction) tests. It does not have a set-aside designation. Cepheid is the prime contractor, and the contract will be performed in Tampa, Florida. The VA is a major customer for Cepheid's federal contract work, which...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, provides reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Department of Veterans Affairs (VA) Veterans Health Administration. The $105,552.60 firm-fixed-price delivery order contract has a completion date of September 30, 2018 and was awarded on October 1, 2017 by the VA's Veterans Integrated Service Network 23. The contract is not set...
- This is a $273,995.82 firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for PCR molecular microbiology testing, including the provision of reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. The contract does not have a set-aside designation. Cepheid has also received other federal...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was made by the Department of Veterans Affairs (VA) Veterans Health Administration. The $148,585 firm fixed price purchase order is for the GENEXPERT product, which supports the agency's Coronavirus COVID-19 response. The award does not utilize a set-aside designation. As the original equipment manufacturer, Cepheid has an ongoing relationship providing reagents, test kits, instruments, and...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $85,270.72 contract is for the delivery of PCR testing kits. Cepheid is a subsidiary of Danaher Corporation, a global science and technology company that has been awarded numerous federal contracts and grants across its portfolio of businesses. This contract does not have a set-aside...
This is a federal purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for $171,262.08 and does not have a set-aside designation. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. Cepheid has also received other federal contracts and grants, including indefinite delivery contracts with the VA and Department of the Army Medical Command for COVID-19 and influenza PCR testing, as well as an IDIQ to supply molecular reagents for its GeneXpert equipment to VA hospitals in Florida. These awards indicate Cepheid's ongoing role as a key supplier of diagnostic testing products and services to various federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($4k) | 8/11/22 | |
| P00002 | Exercise an Option | $35.0k | 1/28/21 | |
| P00001 | Exercise an Option | $35.0k | 12/11/19 | |
| Not listed | Not listed | $35.0k | 1/29/19 |